Searchable abstracts of presentations at key conferences in endocrinology

ea0044p155 | Neuroendocrinology and pituitary | SFEBES2016

Biliary ultrasound and liver function testing in acromegaly before and after 6 months of somatostatin analogue therapy

Cope Rosanne M A , Powlson Andrew S , Case Sarah J , Koulouri Olympia , Gurnell Mark

Background and aims: We have previously reported an increased prevalence of gallbladder polyps in treatment-naive acromegaly when compared with the general population (29 vs 4.6%), with potential implications for future malignant transformation and screening. However, little is known about biochemical markers of liver function in active acromegaly, or in response to treatment. Furthermore, somatostatin analogue (SSA) therapy is associated with the development of gallstones. He...